Sai Parenteral's Limited (NSE:SAIPARENT)

Market Cap	21.50B
Revenue (ttm)	3.90B +302.4%
Net Income	142.59M +225.8%
EPS	4.36 +42.0%
Shares Out	44.18M
PE Ratio	111.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	170,762
Average Volume	111,127
Open	487.30
Previous Close	480.10
Day's Range	479.55 - 493.00
52-Week Range	392.00 - 526.30
Beta	n/a
RSI	63.57
Earnings Date	May 23, 2026

About Sai Parenteral's

Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally. Its portfolio includes formulation products across various therapeutic areas, such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, and dermatology in various dosage forms, including injectables, tablets, capsules, liquid orals, and ointments. The company ...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1988
• Employees: 296
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SAIPARENT

Financial Performance

In fiscal year 2026, Sai Parenteral's's revenue was 3.90 billion, an increase of 138.81% compared to the previous year's 1.63 billion. Earnings were 142.59 million, a decrease of -1.35%.